SCHEMBL27409246

SCHEMBL27409246

OB(O)c1ccc(CNc2ncnc3nc[nH]c23)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.70
LMNA P02545 7/20 0.69
TSHR P16473 6/20 0.69
CYP1A2 P05177 3/20 0.69
MAPK1 P28482 2/20 0.69
CDK2 P24941 2/20 0.69
CYP2D6 P10635 1/20 0.69
KDR P35968 2/20 0.60
AURKA O14965 1/20 0.60
DAPK3 O43293 1/20 0.60
JAK2 O60674 1/20 0.60
PRKD3 O94806 1/20 0.60
MAP4K4 O95819 1/20 0.60
PAK4 O96013 1/20 0.60
ABL1 P00519 1/20 0.60
LCK P06239 1/20 0.60
CSF1R P07333 1/20 0.60
RET P07949 1/20 0.60
PDGFRB P09619 1/20 0.60
FGFR1 P11362 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1443429 0.85 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL30242978 0.85 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL722910 0.82 LMNA (0.76) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL4920202 0.82 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL1443705 0.82 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL723526 0.82 PRMT1 (1.00) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL4922399 0.82 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL4920555 0.82 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL4917703 0.82 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1
SCHEMBL4921836 0.82 PRMT1 (0.75) PRMT1LMNATSHRCYP1A2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS ENPP1, ENPP3, ENTPD5 PRMT1 1246/4885LMNA 2452/4885TSHR 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.